Fig. 1 · Structure

Documents & Downloads

AV-412

Cat. No. A11028 CAS 451493-31-5

EGFR inhibitor

AV-412 is an EGFR/HER2 inhibitor that binds to and inhibits the epidermal growth factor receptor (EGFR) and the human epidermal growth factor receptor 2 (HER2), which may result in the inhibition of tumor growth and angiogenesis.

In Stock

Publications for AV-412

1 publication citing this product

  1. Le Zhang, .et al. , Oncotarget, 2016, Apr 12; 7(15): 19948-19959 PMID: 26942566

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Biological Activity

Target & Activity

Target Activity Value
EGFR IC50 0.75 nM
EGFR(L858R) IC50 0.5 nM
EGFR(T790M) IC50 0.79 nM
EGFR(L858R/T790M) IC50 2.3 nM
ErbB2 IC50 19 nM

AV-412 Research Summary

This section summarizes 2 in vitro studies of AV-412 from 1 published reference. In vitro models include 8505C; KTC-1.

AV-412 In Vitro Studies

In 8505C cells, treatment with the study compound for 48 hrs showed inhibitory effects on cell viability. Vehicle alone served as the positive control. KTC-1 cells were incubated with the tested compound for 48 hrs, with dimethyl sulfoxide (DMSO) as the vehicle. The compound showed inhibitory effects on cell viability. [1]

Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.

Inhibitory Effects on Thyroid Cell Viability

Cell-based study · 8505C [1]

In 8505C cells, treatment with the study compound for 48 hrs showed inhibitory effects on cell viability. Vehicle alone served as the positive control.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
cell viabilityReported result showed inhibitory effects on thyroid 8505C and KTC-1 cells[1]

Literature-Reported Treatment Conditions

Exposure duration
48 hrs incubation
Vehicle
dimethyl sulfoxide (DMSO)
Reported limits
Not stated in the sentences used: dose, route.
Methods and source locations

Compound reported in the paper: AV-412

Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.

RESULTS > High-throughput screening and hit selection (S5); MATERIALS AND METHODS > Chemicals and reagents (S36); Figure 1 legend (S101, S102)

cell viability: cell viability; comparator: positive control (100%) treated with vehicle alone — RESULTS > High-throughput screening and hit selection (S5); Figure 1 legend (S101)

Inhibitory Effects on Thyroid Cell Viability

Cell-based study · KTC-1 [1]

KTC-1 cells were incubated with the tested compound for 48 hrs, with dimethyl sulfoxide (DMSO) as the vehicle. The compound showed inhibitory effects on cell viability.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
cell viabilityReported result showed inhibitory effects on thyroid 8505C and KTC-1 cells[1]

Literature-Reported Treatment Conditions

Exposure duration
48 hrs incubation
Vehicle
dimethyl sulfoxide (DMSO)
Reported limits
Not stated in the sentences used: dose, route.
Methods and source locations

Compound reported in the paper: AV-412

Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.

RESULTS > High-throughput screening and hit selection (S5); MATERIALS AND METHODS > Chemicals and reagents (S36); Figure 1 legend (S101, S102)

cell viability: cell viability; comparator: positive control (100%) treated with vehicle alone — RESULTS > High-throughput screening and hit selection (S5); Figure 1 legend (S101)

Specifications

Manufacturer Adooq Bioscience
Actions Inhibitor
CAS Number 451493-31-5
Applications EGFR inhibitor
Formula C27H28ClFN6O.2C7H8O3S
Molecular Weight 851.4
Synonyms MP-412
SMILES
CC1=CC=C(C=C1)S(=O)(=O)O.CC1=CC=C(C=C1)S(=O)(=O)O.CC(C)(C#CC1=CC2=C(C=C1NC(=O)C=C)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)N4CCN(CC4)C

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

AV-412 Research References

  1. [1] Zhang L, Yang Z, Granieri L, et al. High-throughput drug library screening identifies colchicine as a thyroid cancer inhibitor. Oncotarget (2016). PMID: 26942566 DOI: 10.18632/oncotarget.7890 Source material

Publications

1 publication citing this product

  1. Le Zhang, .et al. , Oncotarget, 2016, Apr 12; 7(15): 19948-19959 PMID: 26942566

Added to your cart

View Cart Checkout
Loading...